Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older

Cunningham, Anthony L., Lal, Himal, Kovac, Martina, Chlibek, Roman, Hwang, Shinn-Jang, Díez-Domingo, Javier, Godeaux, Olivier, Levin, Myron J., McElhaney, Janet E., Puig-Barberà, Joan, Vanden Abeele, Carline, Vesikari, Timo, Watanabe, Daisuke, Zahaf, Toufik, Ahonen, Anitta, Athan, Eugene, Barba-Gomez, Jose F., Campora, Laura, de Looze, Ferdinandus, Downey, H. Jackson, Ghesquiere, Wayne, Gorfinkel, Iris, Korhonen, Tiina, Leung, Edward, McNeil, Shelly A., Oostvogels, Lidia, Rombo, Lars, Smetana, Jan, Weckx, Lily, Yeo, Wilfred, Heineman, Thomas C.·2016·New England Journal of Medicine

DOI 10.1056/nejmoa1603800

Cited by (1,000)

Items 401–500 of 1,000

Modeling the impact of combined vaccination programs against varicella and herpes zoster in Norway
Sabina Marchetti, Giorgio Guzzetta, Elmira Flem, Gražina Mirinavičiūtė, Gianpaolo Scalia Tomba, Piero Manfredi · 2018 · Vaccine
A novel nonlive, adjuvanted herpes zoster subunit vaccine: a report on the emerging clinical data and safety profile
Federica Brosio, Giulia Masetti, Giulio Matteo, Armando Stefanati, Giovanni Gabutti · 2018 · Infection and Drug Resistance
Zoster Vaccination in Older Adults: Efficacy and Public Health Implications
Janet E. McElhaney, Chris P. Verschoor, Graham Pawelec · 2019 · The Journals of Gerontology Series A
Herpes Zoster in Persons Living with HIV-1 Infection: Viremia and Immunological Defects Are Strong Risk Factors in the Era of Combination Antiretroviral Therapy
Nathaniel B. Erdmann, Heather A. Prentice, Anju Bansal, Howard W. Wiener, Greer Burkholder, Sadeep Shrestha, Jianming Tang · 2018 · Frontiers in Public Health
Herpes zoster prevention: A difficult problem to solve
Susanna Esposito, Nicola Principi · 2017 · Vaccine
Indian Academy of Pediatrics (IAP) Advisory Committee on Vaccines and Immunization Practices (ACVIP): Recommended Immunization Schedule (2023) and Update on Immunization for Children Aged 0 Through 18 Years
M. Indra Shekhar Rao, Srinivas G. Kasi, Shashi Kant Dhir, Arun Wadhwa, B. Rajsekhar, Chandra Mohan Kumar, Sanjay Kewalchand Lalwani, Bhaskar Shenoy, T. M. Ananda Kesavan, Srinivas Kalyani et al. · 2024 · Indian Pediatrics
Specific and cumulative infection burden and mild cognitive impairment and dementia: A population-based study
Rong Shi, Shuyan Yu, Anis Larbi, Tze Pin Ng, Yanxia Lu · 2024 · Brain Behavior and Immunity
Heterologous Prime-Boost Immunization Strategies Using Varicella-Zoster Virus gE mRNA Vaccine and Adjuvanted Protein Subunit Vaccine Triggered Superior Cell Immune Response in Middle-Aged Mice
Dongdong Li, Lijun Bian, Lili Cui, Jingying Zhou, Gaotian Li, Xiaoyan Zhao, Liao Xing, Jiaxing Cui, Bo Sun, Chunlai Jiang et al. · 2024 · International Journal of Nanomedicine
Current status of immunisation for herpes zoster
Anthony Lawrence Cunningham, Kerrie J. Sandgren, Janette Taylor · 2025 · Human Vaccines & Immunotherapeutics
Post-marketing safety surveillance for the recombinant zoster vaccine (Shingrix), vaccine adverse event reporting system, United States, October 2017–April 2024
Yamin Shu, Wenxin Cheng, Xucheng He, Liu Huang, Wei J. Chen, Qilin Zhang · 2025 · Preventive Medicine Reports
Managing varicella zoster virus contact and infection in patients on anti-rheumatic therapy
Matthew J. Cates, Matthew Donati, Sophie Gillet, Andrew Ustianowski, James Benjamin Galloway · 2017 · Lara D. Veeken
The situation of vaccines for the prevention of infections in adults: An opinion paper on the situation in Spain.
Emilio Bouza, Julio Ancochea, Magda Campins, JM Eiros-Bouza, J. Fargas, García Rojas A, Dea Rosa Gracia, A Gutiérrez Sánchez, Aurora Limia, J A López et al. · 2019 · PubMed Central
Optimizing Vaccination in Adult Patients With Liver Disease and Liver Transplantation
Yoona Rhee, Beverly E. Sha, Carlos A.Q. Santos · 2020 · Clinical Liver Disease
Corneal Allograft Rejection Associated With Herpes Zoster Recombinant Adjuvanted Vaccine
Alice Y. Matoba · 2021 · Cornea
Safety and reactogenicity of the adjuvanted recombinant zoster vaccine: experience from clinical trials and post-marketing surveillance
Joseph Fiore, Maribel Co-van der Mee, Andrés Maldonado, Lisa Glasser, Phil Watson · 2021 · Therapeutic Advances in Vaccines and Immunotherapy
Research Trends and Hotspots on Herpes Zoster: A 10-Year Bibliometric Analysis (2012–2021)
Jian Zhang, Xu Han, Diansan Su, Xiyao Gu, Weifeng Yu · 2022 · Frontiers in Medicine
Development of a vaccine against cytomegalovirus infection and disease
Kate Luisi, Mayuri Sharma, Dong Liang Yu · 2017 · Current Opinion in Virology
Use of Real-world Evidence to Evaluate the Effectiveness of Herpes Zoster Vaccine
Hung-Fu Tseng, L. Sy · 2018 · Journal of Infectious Diseases
Evaluation of two frailty indices, with practical application in a vaccine clinical trial
Desmond Curran, Melissa Kathryn Andrew, Myron J. Levin, Elisa Turriani, Sean Matthews, Charles M. Fogarty, Nicola P. Klein, Katrijn Grupping, Lidia Oostvogels, Kenneth E. Schmader · 2019 · Human Vaccines & Immunotherapeutics
The 2025 British Society for Rheumatology guideline for the prescription and monitoring of conventional synthetic disease-modifying anti-rheumatic drugs
Katie Bechman, Kaiyang Song, Abhishek Abhishek, Maryam A. Adas, Alison Ahmed, Lisa Bray, Alan Davidson, Samundeeswari Deepak, Mrinalini Dey, Hope De Vere et al. · 2025 · Rheumatology
Noninferior Immunogenicity and Consistent Safety of Respiratory Syncytial Virus Prefusion F Protein Vaccine in Adults 50–59 Years Compared to ≥60 Years of Age
Murdo Ferguson, Tino F. Schwarz, Sebastián A Núñez, Juan José Rodríguez-García, Marek Mital, Carlos Zala, Bernhard Schmitt, Nicole Toursarkissian, Dolores Ochoa Mazarro, Josef Großkopf et al. · 2024 · Clinical Infectious Diseases
A Medical Records Review Study Assessing Safety of Zoster Vaccine Recombinant, Adjuvanted in Patients With Rheumatic Disease
Surbhi Gupta, Reuben J. Arasaratnam, E. Blair Solow, Puneet Bajaj · 2021 · JCR Journal of Clinical Rheumatology
Systematic review and meta-analysis: the effectiveness and safety of acupuncture in the treatment of herpes zoster
Tao Qi, Lan Hua, Chao Zhong, Ruwen Zhang, Huamei Zhang, Fang Zhu, Bing Ji · 2022 · Annals of Palliative Medicine
A Variant Allele in Varicella-Zoster Virus Glycoprotein B Selected during Production of the Varicella Vaccine Contributes to Its Attenuation
Tomohiko Sadaoka, Daniel Pearce Depledge, Labchan Rajbhandari, Judith Breuer, Arun Venkatesan, Jeffrey I. Cohen · 2022 · mBio
Hospitalization burden related to herpes zoster infection during the COVID-19 pandemic in Spain (2020-2021)
Victor-Manuel Irigoyen-Mansilla, Ruth Gil-Prieto, Enrique Gea–Izquierdo, José Luis Barrio–Fernández, Valentín Hernández‐Barrera, Ángel Gil de Miguel · 2023 · Human Vaccines & Immunotherapeutics
Adjuvant AS01 activates human monocytes for costimulation and systemic inflammation
Carson L. Smith, Brian Richardson, Michael Rubsamen, Mark J. Cameron, Cheryl Cameron, David H. Canaday · 2023 · Vaccine
Low Rates of Vaccination for Herpes Zoster in Older People Living With HIV
Kristine Mace Erlandson, Amber C Streifel, Alexander R. Novin, Kellie L. Hawkins, Clayton L. Foster, Jacob A. Langness, Mary T. Bessesen, Julian Falutz, Abeer Moanna, David J. Looney et al. · 2018 · AIDS Research and Human Retroviruses
Real-World Evidence for Regulatory Decisions: Concomitant Administration of Zoster Vaccine Live and Pneumococcal Polysaccharide Vaccine
Katia J. Bruxvoort, Lina S. Sy, Yi Luo, Hung Fu Tseng · 2018 · American Journal of Epidemiology
Patient report of herpes zoster pain: Incremental benefits of zoster vaccine live
Katia J. Bruxvoort, Anna S. Liang, Rafael Harpaz, Lei Qian, Lina S. Sy, Philip S. LaRussa, D. Scott Schmid, Yi Luo, Harpreet S. Takhar, Hung Fu Tseng · 2019 · Vaccine
Varicella Zoster Virus in Inflammatory Bowel Disease Patients: What Every Gastroenterologist Should Know
Philipp Schreiner, Nicolas Johannes Mueller, Jan Sven Fehr, Michel H. Maillard, Stephan Brand, Pierre Michetti, Alain M. Schoepfer, Sophie Restellini, Marianne Vullièmoz, Stephan R. Vavricka et al. · 2020 · Journal of Crohn s and Colitis
Fatal case of cutaneous‐sparing orolaryngeal zoster in a renal transplant recipient
Elie El Helou, Matthew H. Grant, Marie Louise Landry, Xinyu Wu, Jon S. Morrow, Maricar F. Malinis · 2017 · Transplant Infectious Disease
Real-world Effectiveness of the Adjuvanted Recombinant Zoster Vaccine in ≥50-year-old Adults With Autoimmune Diseases
Dagna O. Constenla, Germain Lonnet, Emmanuel Aris, R.K. Ramsanjay, Nathalie Servotte, Agnes Mwakingwe-Omari, Hannah Alsdurf, Huifeng Yun · 2025 · The Journal of Infectious Diseases
Real-world effectiveness of recombinant zoster vaccine in self-identified Chinese individuals aged ≥50 years in the United States
Ana Florea, Lina S. Sy, Lei Qian, Bradley K. Ackerson, Yi Luo, Jun Wu, Yanjun Cheng, Jennifer H Ku, Leticia I Vega Daily, Harpreet S. Takhar et al. · 2024 · Human Vaccines & Immunotherapeutics
The inactivated herpes zoster vaccine HZ/su induces a varicella zoster virus specific cellular and humoral immune response in patients on dialysis
Franziska Hielscher, Tina Schmidt, Martin Enders, Sarah Leyking, Markus K. Gerhart, Kai van Bentum, Janine Mihm, David Schub, Urban Sester, Martina Sester · 2024 · EBioMedicine
Low-Dose Valacyclovir for Postherpetic Neuralgia in the Zoster Eye Disease Study
David B. Warner, Bennie H. Jeng, Jiyu Kim, Mengling Liu, Andrea B. Troxel, Judith S. Hochman, Keith H. Baratz, Shahzad Ihsan Mian, Mazen Y. Choulakian, Jay J. Meyer et al. · 2025 · JAMA Ophthalmology
Queratopatía neurotrófica postherpética: etiopatogenia, clínica y terapias actuales
Francisco Pérez-Bartolomé, David Mingo‐Botín, Elisabet de Dompablo, Pablo de-Arriba-Palomero, Francisco Arnalich‐Montiel, F.J. Muñoz Negrete · 2019 · Archivos de la Sociedad Española de Oftalmología
The burden of herpes zoster disease in Norway
Gražina Mirinavičiūtė, Else Quist‐Paulsen, Arne Broch Brantsæter, Elmira Flem · 2019 · Vaccine
Immune response to varicella-zoster virus before and after renal transplantation
Christien Rondaan, Anoek A. E. de Joode, Lei Wang, Mark Siderius, Elisabeth Raveling‐Eelsing, Coretta van Leer‐Buter, Sander van Assen, Nicolaas A. Bos, Johanna Westra · 2020 · Antiviral Research
An Analysis of Spontaneously Reported Data of Vesicular and Bullous Cutaneous Eruptions Occurring Following Vaccination with the Adjuvanted Recombinant Zoster Vaccine
Paola Pirrotta, Fernanda Tavares Da Silva, Maribel Miranda Co, Nicolas Lecrenier, Caroline Hervé, Jens‐Ulrich Stegmann · 2021 · Drug Safety
Comparing Prodrugs with Acyclovir for Treating Postherpetic Neuralgia among Herpes Zoster Patients: A Systematic Review and Meta-Analysis
Chung‐Hsin Yeh, Ko-Shih Chang, Sheng‐Shiung Huang, Shiow‐Luan Tsay, Jung‐Mei Tsai, Ya‐Jung Wang · 2022 · Healthcare
Clinical Development of mRNA Vaccines: Challenges and Opportunities
Allison August, Luis Brito, Robert Paris, Tal Z. Zaks · 2022 · Current topics in microbiology and immunology
Carbohydrate fatty acid monosulphate: oil-in-water adjuvant enhances SARS-CoV-2 RBD nanoparticle-induced immunogenicity and protection in mice
Etsuro Nanishi, Francesco Borriello, Hyuk‐Soo Seo, Timothy R. O’Meara, Marisa E. McGrath, Yoshine Saito, Jing Chen, Joann Diray‐Arce, Kijun Song, Andrew Z. Xu et al. · 2023 · npj Vaccines
Predictors of 5-Year Persistence of Antibody Responses to Zoster Vaccines
Adriana Weinberg, D. Scott Schmid, Jessica W. T. Leung, Michael Joseph Johnson, Congrong Miao, Myron J. Levin · 2023 · The Journal of Infectious Diseases
Vaccination to Reduce Reactivation of Herpes Simplex Virus 2
Jeffrey I. Cohen · 2017 · The Journal of Infectious Diseases
A Cost-effectiveness Analysis of an Adjuvanted Subunit Vaccine for the Prevention of Herpes Zoster and Post-herpetic Neuralgia
Christopher F Carpenter, Annas Aljassem, Jerry Stassinopoulos, Giovanni Pisacreta, David W. Hutton · 2019 · Open Forum Infectious Diseases
Age-Associated Differences in Infection of Human Skin in the SCID Mouse Model of Varicella-Zoster Virus Pathogenesis
Leigh Zerboni, Phillip Sung, Gordon Lee, Ann M. Arvin · 2018 · Journal of Virology
Recombinant Zoster Vaccine (Shingrix) to Prevent Herpes Zoster
Jacqueline Sly, Allyssa L. Harris · 2018 · Nursing for Women s Health
Regulatory T cells and vaccine effectiveness in older adults. Challenges and prospects
Alexander Batista-Duharte, Alejandra Pera, Salvador Francisco Aliño, Rafael Solana · 2021 · International Immunopharmacology
Preventing Shingles and Its Complications in Older Persons
Kathleen Maletic Neuzil, Marie R. Griffin · 2016 · New England Journal of Medicine
Vaccine-induced protection in aging adults and pandemic response
Schenkelberg, Theodore · 2021 · Biochemical and Biophysical Research Communications
An Analysis of How Herpes Zoster Pain Affects Health-related Quality of Life of Placebo Patients From 3 Randomized Phase III Studies
Sean Matthews, Desmond Curran, Eliazar Sabater Cabrera, Céline Boutry, Nicolas Lecrenier, Anthony Lawrence Cunningham, Kenneth E. Schmader · 2023 · Clinical Journal of Pain
Advances in understanding the mechanism of action of adult vaccines
Anthony Lawrence Cunningham, Kerrie J. Sandgren, Naomi R. Truong · 2023 · Journal of Clinical Investigation
Time to talk to adults with rheumatic diseases about herpes zoster vaccination
Mischa Pier, Gertjan Wolbink, Laura Boekel · 2024 · The Lancet Rheumatology
Lack of functional TCR-epitope interaction is associated with herpes zoster through reduced downstream T cell activation
Marlies Boeren, Nicky de Vrij, My Kieu Ha, Sebastiaan Valkiers, Aisha Hegab Souquette, Sofie Gielis, Maria S. Kuznetsova, Jolien Schippers, Esther Bartholomeus, Johan Van den Bergh et al. · 2024 · Cell Reports
Knowledge, Attitudes, and Practices Regarding Herpes Zoster Vaccination Among Specialists
David Singer, Carolyn Sweeney, Nikita Stempniewicz, Maria Reynolds, Diana Garbinsky, Sara A. Poston · 2024 · Population Health Management
Effectiveness of recombinant zoster vaccine in reducing herpes zoster incidence and all-cause mortality among patients with rheumatoid arthritis: a retrospective cohort study of 21,046 individuals from TriNetX U.S. Collaborative Network
Ying-Li Lin, Shiow‐Ing Wang, James Cheng-Chung Wei · 2025 · EClinicalMedicine
Effectiveness of the Adjuvanted Recombinant Zoster Vaccine in Adults ≥50 Years in the United States
Hung Fu Tseng, Lina S. Sy, Bradley K. Ackerson, Emily A. Rayens, Jun Wu, Yi Luo, Yanjun Cheng, Jennifer H Ku, Leticia I Vega Daily, Harpreet S. Takhar et al. · 2025 · Clinical Infectious Diseases
Blunted vaccines responses after ocrelizumab highlight need for immunizations prior to treatment
Ide Smets, Saúl Reyes, David Baker, Gavin Giovannoni · 2021 · Multiple Sclerosis and Related Disorders
Humoral Immunity to Varicella Zoster Virus in Patients with Systemic Lupus Erythematosus and Rheumatoid Arthritis Compared to Healthy Controls
Marco Krasselt, Christoph Baerwald, Uwe G. Liebert, Olga Seifert · 2021 · Vaccines
National Asthma Education and Prevention Program 2020 Guidelines: What’s Important for Primary Care
Murphy Murphy · 2021 · The Journal of Family Practice
Thrombosis formation after COVID-19 vaccination Immunological Aspects: Review article
Hisham Ali Waggiallah · 2021 · Saudi Journal of Biological Sciences
Ramsay Hunt syndrome and mandibular alveolar bone necrosis following herpes zoster: A case report and literature review
Maojia Yin, Panchuan Huang, Sen Yang, Wuchao Wang · 2022 · Frontiers in Neurology
Efficacy, reactogenicity, and safety of the adjuvanted recombinant zoster vaccine for the prevention of herpes zoster in Chinese adults ≥ 50 years: A randomized, placebo-controlled trial
Diana Alexandra Echeverria Proano, Fengcai Zhu, Xiaodong Sun, Jesús Zoco, Jyoti Soni, Neeraj Parmar, Omar Ali, on behalf of Zoster-076 Study Group, Zhuoying Huang, Xiang Guo et al. · 2024 · Human Vaccines & Immunotherapeutics
Zoster Vaccine Recombinant, Adjuvanted
Kalvin Stoker, Terri L. Levien, Danial E. Baker · 2018 · Hospital Pharmacy
Herpes zoster subunit vaccine for the prevention of herpes zoster
Melanie R. Symoniak, Pejman Farrokh, Mona A. Gandhi, Judianne C. Slish · 2018 · American Journal of Health-System Pharmacy
Potential cost-effectiveness of adjuvanted herpes zoster subunit vaccine for older adults in Hong Kong
Joyce H. S. You, Wai‐Kit Ming, Chak-fei Lee, Owen Tak‐Yin Tsang, Paul K.S. Chan · 2018 · Vaccine
Herpes Zoster and Herpes Zoster Vaccine Rates Among Adults Living With and Without HIV in the Veterans Aging Cohort Study
Kellie L. Hawkins, Kirsha S. Gordon, Myron J. Levin, Adriana Weinberg, Catherine T. Battaglia, Maria C. Rodriguez‐Barradas, Sheldon T. Brown, David Rimland, Amy C. Justice, Janet Tate et al. · 2018 · JAIDS Journal of Acquired Immune Deficiency Syndromes
Optimal gender-specific age for cost-effective vaccination with adjuvanted herpes zoster subunit vaccine in Chinese adults
Joyce H. S. You, Wai‐Kit Ming, Owen Tak‐Yin Tsang, Paul K.S. Chan · 2019 · PLoS ONE
Vaccination for the post-kidney transplant population
Shilpa R. Jain, Deepali Kumar · 2019 · Current Opinion in Nephrology & Hypertension
The Impact of Human Herpesviruses in Clinical Practice of Inflammatory Bowel Disease in the Era of COVID-19
Shuhei Hosomi, Yu Nishida, Yasuhiro Fujiwara · 2021 · Microorganisms
A randomized lot-to-lot immunogenicity consistency study of the candidate zoster vaccine HZ/su
Ana Strezova, Olivier Godeaux, Naresh Aggarwal, Geert G Leroux-Roels, Marta López‐Fauqued, Pierre Van Damme, Carline Vanden Abeele, Ilse Vastiau, Thomas Charles Heineman, Himal Lal · 2017 · Vaccine
Cost-Effectiveness of Recombinant Zoster Vaccine for Adults Aged ≥50 Years in China
Minghuan Jiang, Xuelin Yao, Jin Peng, Liuxin Feng, Yue Ma, Xinke Shi, Yu Fang, Hai Fang · 2023 · American Journal of Preventive Medicine
Global herpes zoster burden in adults with asthma: a systematic review and meta-analysis
Kevin J. Mortimer, Álvaro Augusto Cruz, Ingrid T. Sepúlveda-Pachón, Anamaria Jorga, Hilde Vroling, Charles Williams · 2024 · European Respiratory Journal
Preventing herpes zoster in immunocompromised patients: Current concepts
Cassandra M. Calabrese, Elizabeth Kirchner, James Fernandez, Leonard H. Calabrese · 2024 · Cleveland Clinic Journal of Medicine
Vaccinations in older adults: Optimization, strategies, and latest guidelines
Aileen Pangilinan, Sharon A. Brangman, Stefan Gravenstein, Kenneth E. Schmader, George A. Kuchel · 2024 · Journal of the American Geriatrics Society
Evaluating the Immunogenicity, Efficacy, and Effectiveness of Recombinant Zoster Vaccine for Global Public Health Policy
Lucy R Williams, Joachim Hombach, Melanie Marti · 2025 · Vaccines
A highly stable lyophilized mRNA vaccine for Herpes Zoster provides potent cellular and humoral responses
Raquel Muñoz-Moreno, Viola Allaj, Eddie Gadee, Julie M. Button, Fernando Diaz, Mohan S. Maddur, Wei Chen, Cheng Hui Hu, Lyndsey T. Martinez, Andreas Giannakou et al. · 2025 · npj Vaccines
Enhanced Potency and Persistence of Immunity to Varicella-Zoster Virus Glycoprotein E in Mice by Addition of a Novel BC02 Compound Adjuvant
Junli Li, Lili Fu, Yang Yang, Guozhi Wang, Aihua Zhao · 2022 · Vaccines
Increased Production of Inflammatory Cytokines after Inoculation with Recombinant Zoster Vaccine in Mice
Tetsuo Nakayama, Akihito Sawada, Takeshi Ito · 2022 · Vaccines
Adjuvant Effects of a New Saponin Analog VSA-1 on Enhancing Homologous and Heterosubtypic Protection by Influenza Virus Vaccination
Noopur Bhatnagar, Ki‐Hye Kim, Jeeva Subbiah, Bo Ryoung Park, Pengfei Wang, Harvinder Singh Gill, Bao‐Zhong Wang, Sang‐Moo Kang · 2022 · Vaccines
Natural History of Herpes Zoster in the Placebo Groups of Three Randomized Phase III Clinical Trials
Desmond Curran, Sean Matthews, Céline Boutry, Nicolas Lecrenier, Anthony Lawrence Cunningham, Kenneth E. Schmader · 2022 · Infectious Diseases and Therapy
Vaccine-Preventable Diseases in Older Adults
Maha Al-Jabri, Christian Rosero, Elie Saade · 2023 · Clinics in Geriatric Medicine
Quillaja brasiliensis nanoparticle adjuvant formulation improves the efficacy of an inactivated trivalent influenza vaccine in mice
Fernando L. Silveira, Mariana Rivera-Patron, Nikita Deshpande, Soledad Sienra, Jackeline Checa, María Moreno, Jose Alejandro Chabalgoity, Samuel Paulo Cibulski, Mariana Baz · 2023 · Frontiers in Immunology
Alpha-Herpesviridae in der Dermatologie
Lara El Hayderi, Albert Rübben, Arjen Nikkels · 2017 · Der Hautarzt
Cost Effectiveness of a Shingles Vaccine Booster for Currently Vaccinated Adults in the U.S.
Phuc Le, Michael B. Rothberg · 2017 · American Journal of Preventive Medicine
Age-Dependent Pre-Vaccination Immunity Affects the Immunogenicity of Varicella Zoster Vaccination in Middle-aged Adults
Marieke van der Heiden, Lia de Rond, Menno C. van Zelm, Guy A. M. Berbers, Annemieke M. H. Boots, Anne‐Marie Buisman · 2018 · Frontiers in Immunology
Current vaccines for the prevention of herpes zoster
Allister G. Gibbons, Anat Galor · 2018 · Current Opinion in Ophthalmology
Application of Modeling Approaches to Explore Vaccine Adjuvant Mode-of-Action
Paul R. Buckley, Kieran Alden, Margherita Coccia, Aurélie Chalon, Catherine Collignon, Stéphane T. Temmerman, Arnaud M. Didierlaurent, Robbert G. Van der Most, Jon Timmis, Claus A. F. Andersen et al. · 2019 · Frontiers in Immunology
The situation of infection in the elderly in Spain: a multidisciplinary opinion document
Emilio Bouza, Francisco José Brenes, Javier Díez‐Domingo, José María Eirós Bouza, José González, Diego Gracia, Ricardo Juarez González, Patricia Muñóz, Roberto Petidier Torregrossa, José Manuel Ribera Casado et al. · 2020 · Revista Española de Quimioterapia
An early look at the second dose completion of the recombinant zoster vaccine in Canadian adults: A retrospective database study
Ashleigh A. McGirr, Tara Bourgoin, Michael E. Wortzman, Brad Millson, Shelly McNeil · 2021 · Vaccine
Adjuvanted recombinant zoster vaccine in solid organ transplant and hematopoietic stem-cell transplant recipients
Jean-Xavier Provost-Olewczynska, Christiane Sigrid Eberhardt · 2022 · Current Opinion in Infectious Diseases
Potentiating pneumococcal glycoconjugate vaccine PCV13 with saponin adjuvant VSA-1
Hyun‐Jung Kim, Jigui Yu, Di Bai, Moon H. Nahm, Pengfei Wang · 2022 · Frontiers in Immunology
High Constitutive Interleukin 10 Level Interferes With the Immune Response to Varicella-Zoster Virus in Elderly Recipients of Live Attenuated Zoster Vaccine
Anne A. Gershon, David G. Brooks, Donald D. Stevenson, William K Chin, Michael B. A. Oldstone, Michael David Gershon · 2018 · The Journal of Infectious Diseases
Risk of Herpes Zoster in Cancer Patients and the Promise of New Vaccines
Kosuke Kawai, Barbara P. Yawn · 2018 · The Journal of Infectious Diseases
Effects of herpes zoster vaccination and antiviral treatment on the risk of stroke: a systematic review and meta-analysis
Yong-hui Jia, Yu-bo Dong, Hai‐yin Jiang, Ai-juan Li · 2023 · Frontiers in Neurology
Immune response to the recombinant herpes zoster vaccine in people living with HIV over 50 years of age compared to non-HIV age-/gender-matched controls (SHINGR’HIV): a multicenter, international, non-randomized clinical trial study protocol
Maxime Hentzien, Fabrice Bonnet, Enos Bernasconi, Emmanuel Biver, Dominique L. Braun, Aline Munting, Karoline Leuzinger, Olivier Leleux, Stefano Musardo, Virginie Prendki et al. · 2024 · BMC Infectious Diseases
Public health impact of herpes zoster vaccination on older adults in Singapore: a modeling study
Helen M. L. Oh, Carol Soo Ching Tan, Charles Williams, Nikolaos Giannelos, Cheryl Ng · 2024 · Human Vaccines & Immunotherapeutics
Recommendations and guidance for herpes zoster vaccination for adults in Taiwan
Kuan‐Yin Lin, Ching-Hsun Wang, Lian-Yi Su, I-Fan Lin, Chia-Wei Liu, Ping-Feng Wu, Wen-Chia Tsai, Chia-Ning Chang, Miao-Chiu Hung, Chien-Hsien Huang et al. · 2024 · Journal of Microbiology Immunology and Infection
Osteonecrosis of the Jaws Associated with Herpes Zoster Infection: A Systematic Review and a Rare Case Report
Antonio Mancini, Fabrizio Chirico, Angelo Michele Inchingolo, Fabio Piras, Valeria Colonna, Pierluigi Marotti, Claudio Carone, Alessio Danilo Inchingolo, Francesco Inchingolo, Gianna Dipalma · 2024 · Microorganisms
Immunological Considerations for the Development of an Effective Herpes Vaccine
Mahmoud Singer, Mohamed Ibrahim Husseiny · 2024 · Microorganisms